Latest Report on Miraculins Inc. (Mom) - Product Pipeline Analysis, 2015 Update | Researchmoz.Us

Researchmoz added Most up-to-date research on "Miraculins Inc. (MOM) - Product Pipeline Analysis, 2015 Update" to its huge collection of research reports.

Miraculins Inc. (Miraculins) is a biotechnology company that acquires, develops and commercializes risk assessment tests, and non invasive diagnostic tests for the healthcare market. The company provides discovery and validation of cancer biomarkers for development of diagnostic tools and therapeutic products. Its products include prevu non-invasive skin cholesterol test and scout DS non-invasive diabetes screening test. Miraculinss testing services utilizes PSP94 RUO kit. The company utilizes the B.E.S.T platform technology for screening and identification of target proteins and peptides related to diseases. Miraculins is headquartered in Winnipeg, Manitoba, Canada.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=461167

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Miraculins Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides...